8.35
前日終値:
$8.81
開ける:
$8.56
24時間の取引高:
47,266
Relative Volume:
0.11
時価総額:
$1.14B
収益:
-
当期純損益:
$-102.09M
株価収益率:
-7.9524
EPS:
-1.05
ネットキャッシュフロー:
$-108.72M
1週間 パフォーマンス:
-0.71%
1か月 パフォーマンス:
-8.04%
6か月 パフォーマンス:
+114.10%
1年 パフォーマンス:
+45.75%
Dbv Technologies Adr Stock (DBVT) Company Profile
名前
Dbv Technologies Adr
セクター
電話
33(0)155427878
住所
107 AVENUE DE LA REPUBLIQUE, CHATILLON
DBVT を他の銘柄と比較する
株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
---|---|---|---|---|---|---|
![]()
DBVT
Dbv Technologies Adr
|
8.35 | 230.03M | 0 | -102.09M | -108.72M | -1.05 |
![]()
ONC
Beone Medicines Ltd Adr
|
245.58 | 26.10B | 3.81B | -644.79M | -669.77M | -6.24 |
![]()
VRTX
Vertex Pharmaceuticals Inc
|
442.05 | 111.96B | 11.10B | -988.90M | -1.26B | -3.92 |
![]()
AKTX
Akari Therapeutics Plc Adr
|
1.35 | 42.96M | 0 | 0 | 0 | 0.00 |
![]()
VRNA
Verona Pharma Plc Adr
|
81.20 | 6.39B | 0 | -153.72M | -103.81M | -2.00 |
![]()
REGN
Regeneron Pharmaceuticals Inc
|
490.28 | 63.52B | 14.09B | 4.50B | 2.96B | 39.28 |
Dbv Technologies Adr Stock (DBVT) Upgrades & Downgrades
日付 | アクション | アナリスト | 評価の変更 |
---|---|---|---|
2023-01-04 | アップグレード | Societe Generale | Hold → Buy |
2022-12-16 | ダウングレード | Goldman | Neutral → Sell |
2022-05-10 | ダウングレード | Goldman | Buy → Neutral |
2021-09-14 | アップグレード | Societe Generale | Hold → Buy |
2021-01-22 | ダウングレード | Societe Generale | Hold → Sell |
2020-11-02 | アップグレード | Societe Generale | Sell → Hold |
2020-08-06 | ダウングレード | Societe Generale | Buy → Sell |
2020-08-05 | 繰り返されました | H.C. Wainwright | Buy |
2020-03-17 | ダウングレード | Stifel | Buy → Hold |
2020-01-09 | アップグレード | Stifel | Hold → Buy |
2019-12-16 | 開始されました | Citigroup | Buy |
2019-09-05 | 再開されました | Morgan Stanley | Equal-Weight |
2019-06-17 | 開始されました | Goldman | Buy |
2018-12-20 | ダウングレード | Barclays | Overweight → Equal Weight |
2018-12-20 | ダウングレード | BofA/Merrill | Buy → Underperform |
2018-12-20 | ダウングレード | Jefferies | Buy → Hold |
2018-12-20 | ダウングレード | Stifel | Buy → Hold |
2017-10-31 | アップグレード | Societe Generale | Sell → Hold |
2017-10-24 | ダウングレード | Societe Generale | Buy → Sell |
2017-10-23 | ダウングレード | Morgan Stanley | Overweight → Equal-Weight |
2017-06-23 | 開始されました | Deutsche Bank | Buy |
2017-03-16 | アップグレード | Societe Generale | Hold → Buy |
2016-09-26 | 開始されました | JMP Securities | Mkt Outperform |
2015-12-03 | 開始されました | Barclays | Overweight |
2015-10-23 | 開始されました | BofA/Merrill | Buy |
すべてを表示
Dbv Technologies Adr (DBVT) 最新ニュース
DBV Technologies (NASDAQ:DBVT) Raised to Sell at The Goldman Sachs Group - Defense World
DBV Technologies (NASDAQ:DBVT) Now Covered by Analysts at The Goldman Sachs Group - Defense World
Goldman Sachs cuts DBV Technologies stock to Sell, target EUR1.30 By Investing.com - Investing.com South Africa
Goldman Sachs cuts DBV Technologies stock to Sell, target EUR1.30 - Investing.com India
Goldman Sachs reinstates DBV Technologies with sell rating, $7.25 target By Investing.com - Investing.com India
Goldman Sachs reinstates DBV Technologies with sell rating, $7.25 target - Investing.com
DBV Technologies (NASDAQ:DBVT) Price Target Raised to $21.00 at JMP Securities - Defense World
European ADRs Rise On S&P Europe Select Index - Finimize
DBV Technologies’ SWOT analysis: peanut allergy treatment stock faces pivotal trial - Investing.com
European ADRs Slip As US Index Notes Mixed Gains And Losses - Finimize
European ADRs Show Optimism As Genfit Leads Gains - Finimize
Comparing DBV Technologies (NASDAQ:DBVT) and Maze Therapeutics (NASDAQ:MAZE) - Defense World
Are You Looking for a Top Momentum Pick? Why DBV Technologies S.A. (DBVT) is a Great Choice - Nasdaq
European ADRs Dip As Pharma And Tech Stocks See Mixed Results - Finimize
Combined General Meeting of June 11, 2025 - GlobeNewswire
DBV Technologies Sets Critical Shareholder Meeting: Key Documents Now Available - Stock Titan
European ADRs Show Modest Gains With Standout Performers - Finimize
StockNews.com Upgrades DBV Technologies (NASDAQ:DBVT) to “Hold” - Defense World
FY2025 EPS Forecast for DBV Technologies Boosted by Analyst - Defense World
What is HC Wainwright’s Estimate for DBVT Q2 Earnings? - Defense World
European ADRs Dip With Mixed Performances Across Key Sectors - Finimize
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of DBV Technologies S.A.DBVT - Barchart.com
HC Wainwright Issues Positive Forecast for DBV Technologies (NASDAQ:DBVT) Stock Price - Defense World
DBV Technologies to Participate in the Citizens JMP Life Sciences Conference - The Manila Times
DBV Technologies stock target raised to $16 by H.C. Wainwright - Investing.com Nigeria
JMP Securities Boosts DBV Technologies (NASDAQ:DBVT) Price Target to $15.00 - Defense World
DBV Technologies (NASDAQ:DBVT) Earns Hold Rating from Analysts at StockNews.com - Defense World
DBV Technologies Reports First Quarter 2025 Financial Results - EIN News
European ADRs Show Strength With Genfit And Novo Nordisk Leading Gains - Finimize
DBV Technologies Secures Massive $306.9M Financing Despite Q1 Losses: Cash Runway Extended - Stock Titan
European ADRs Show Gains Despite Mixed Performances In Key Sectors - Finimize
European Stocks Shine In The US With Strong Gains - Finimize
StockNews.com Initiates Coverage on DBV Technologies (NASDAQ:DBVT) - Defense World
JMP maintains DBVT stock with $10 target, positive trial outlook - Investing.com
Vaxcyte (NASDAQ:PCVX) versus DBV Technologies (NASDAQ:DBVT) Critical Survey - The AM Reporter
DBV Technologies (NASDAQ:DBVT) & Vaxcyte (NASDAQ:PCVX) Critical Contrast - Defense World
Dbv Technologies Adr (DBVT) 財務データ
収益
当期純利益
現金流量
EPS
大文字化:
|
ボリューム (24 時間):